Novogen NVGN surged 48.66% to $2.9840 at 9:45 am. Novogen shares have jumped 136.43% over the past 52 weeks, while the S&P 500 index has gained 14.47% in the same period.
Furiex Pharmaceuticals FURX shares advanced 47.13% to $31.25. Analysts at Canaccord initiated coverage on shares of Furiex with a “buy” rating..
Keryx Biopharmaceuticals KERX surged 43.76% to $4.93. Keryx Biopharmaceuticals announced successful top-line results from the long-term Phase 3 study of Zerenex™ for the treatment of hyperphosphatemia in patients with end-stage renal disease on dialysis.
Idenix Pharmaceuticals IDIX climbed 13.09% to $5.35. Idenix Pharmaceuticals announced a non-exclusive collaboration with Janssen Pharmaceuticals to initiate Phase II All-oral combination studies.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in